A Series of Genes for Predicting Responses to Anti-Tumor Necrosis Factor α Therapy in Crohn’s Disease

Background: Patients with Crohn’s disease (CD) experience severely reduced quality of life, particularly those who do not respond to conventional therapies. Antitumor necrosis factor (TNF)α is commonly used as first-line therapy; however, many patients remain unresponsive to this treatment, and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Kai, Zhang, Chao, Deng, Minzi, Luo, Weiwei, Ma, Kejia, Xu, Jiahao, Wu, Xing, Yang, Yuanyuan, Wang, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065476/
https://www.ncbi.nlm.nih.gov/pubmed/35517818
http://dx.doi.org/10.3389/fphar.2022.870796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065476/
https://www.ncbi.nlm.nih.gov/pubmed/35517818
http://dx.doi.org/10.3389/fphar.2022.870796

Ejemplares similares